CompoAtlas

Lactibiotic

Natural health product licensed in Canada

Other names
Megatil Lactibiotic
Licence holder
Prébionature Inc.
NPN or DIN-HM
80138326
Status
Active licence
Licence date
4 February 2025
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Cellulose microcristalline, Maltodextrine, Hypromellose, Sucrose, Extrait de tiges/feuilles de Bambusa vulgaris, Carbonate de magnésium, Ascorbate de sodium

PopulationAgeQuantity per servingFrequency
Population not specifiedminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps to reduce breast pain associated with mastitis in women during lactation. Helps support breast health during lactation. Helps to reduce breast pain associated with infectious mastitis in lactating women. Helps to reduce breast pain associated with infectious mastitis in breastfeeding women. Helps to reduce mastitis associated breast pain in women during lactation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80138326

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line